Navigation Links
Senesco Technologies Reports First Quarter Fiscal 2010 Financial Results
Date:11/17/2009

NEW BRUNSWICK, N.J., Nov. 17 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT) today reported financial results for the three months ended September 30, 2009.

Net loss for the three month period ended September 30, 2009 was $189,296, or $0.01 per share, compared with a net loss of $1,181,406, or $0.06 per share, for the three month period ended September 30, 2008. This decrease in net loss was primarily the result of an increase in non-cash income related to the change in fair value of a warrant liability, which was partially offset by an increase in operating expenses and non-cash expenses associated with the outstanding convertible notes and a decrease in revenue and interest income.

Quarterly and Recent Highlights

  • Senesco presented pre-clinical stability and biological activity data on multiple myeloma drug candidate SNS-01 at the 2009 American Association for Cancer Research (AACR)-National Cancer Institute (NCI)-European Organization for Research and Treatment of Cancer (EORTC) Molecular Targets and Cancer Therapeutics Conference
  • Certain Senesco insiders entered into definitive stock purchase agreements to purchase all of the convertible debentures, warrants and common stock which are held by Stanford Venture Capital Holdings, Inc. and/or Stanford International Bank, Ltd.
  • Senesco entered into separate funding agreements, totaling $1.7 million, with Partlet Holdings Ltd., certain members of Senesco's Board of Directors and certain accredited investors, including Cato Holding Company, which is the venture capital affiliate of Cato Research Ltd., a global contract research and development organization currently assisting Senesco with its SNS-01 development program; with the emphasis on initiating a Phase I clinical
    '/>"/>

SOURCE Senesco Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
2. Senesco Announces H1N1 Influenza Survival Test Results in Mice
3. Senesco Chooses VGXI to Produce Factor 5A Plasmid
4. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
5. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
6. Senesco Technologies Initiates Preclinical Studies for Cancer Target
7. EF Johnson Technologies Announces Third Quarter Results
8. Ionian Technologies, Inc. Signs Molecular Diagnostic Manufacturing Agreement With Roche Diagnostics
9. Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes
10. ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance
11. Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... WOONSOCKET, R.I. , March 6, 2015 ... Chief Medical Officer of CVS Health (NYSE: ... on Health in Washington, D.C. ... a critical role in addressing health care cost and ... stress.  After making CVS/pharmacy the first national pharmacy chain ...
(Date:3/6/2015)... WILMINGTON, Del. , March 6, 2015 /PRNewswire/ ... Patent and Trademark Office,s publication of U.S. Patent ... Eating Disorder."  The ,249 Patent Application features claimed methods ... may be used to treat Binge Eating Disorder ... "information material," or "flyer or an advertisement," as ...
(Date:3/5/2015)... 5, 2015  Pfenex Inc. (NYSE MKT: PFNX), ... of biosimilar therapeutics including high value and difficult ... quarter and full year 2014 financial results will ... the market opens for trading.  At 9:00 am ... call to discuss the financial results and provide ...
Breaking Medicine Technology:CVS Health Chief Medical Officer to Address National Business Group on Health on Value of Pharmacy Care in Evolving Health Care System 2CVS Health Chief Medical Officer to Address National Business Group on Health on Value of Pharmacy Care in Evolving Health Care System 3Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2Pfenex To Report Fourth Quarter and Full Year 2014 Results and Provide Business Update 2
(Date:3/6/2015)... Jvion, the Atlanta-based leader in ... Clostridium Difficile (C Diff) predictive use case for ... case is the latest in a broad compliment ... chronic conditions, and individual illnesses. Using the firm’s ... flags at risk individuals to help support clinician ...
(Date:3/6/2015)... TX (PRWEB) March 06, 2015 Yisrayl ... in Abilene, Texas, has released a new publication explaining ... working. , The article titled “Microorganisms Do ... document explaining how tiny microorganisms were created and designed ... is aware of some of the functions of these ...
(Date:3/6/2015)... Springs, FL (PRWEB) March 06, 2015 The ... present March 2015 air dates for Spokane, Washington and vicinity. ... colorful places to shop and dine, and many outdoor activities. ... industry supporting the local economy. Six major hospitals call the ... to the Canadian border. The medically-focused cable TV program will ...
(Date:3/6/2015)... March 06, 2015 The Public ... awarded five-year accreditation status to seven more health departments. ... another 1.3 million people can now be assured that ... promote the health of their communities. , Public health ... the health of people and communities. Across the nation, ...
(Date:3/5/2015)... 2015 This week, 60 ... low-cost laminate flooring products, initiating widespread concern from ... building materials made primarily from bamboo, stands behind ... their flooring products for volatile organic compounds (VOCs) ... International (BMH). Results from formaldehyde emissions testing ...
Breaking Medicine News(10 mins):Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2Health News:Yisrayl Hawkins Tells Scientists Exactly What Makes Life Function Properly in New Publication 2Health News:The Health Briefs TV Show to Air in Spokane, Washington 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 3Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2
... -- The role that air pollution plays in heart ... be underestimated, according to researchers. A small study ... changes in the heart,s electrical system when the participants ... that air pollution may interfere with the heart,s ability ...
... By Randy Dotinga HealthDay Reporter , TUESDAY, ... people walk may provide a glimpse into how many years ... that a formula that includes gait predicted older people,s future ... health conditions as blood pressure and heart disease. Walking ...
... for the 2013 America,s Cup has been announced, a study ... smooth sailing. The study was published recently in the journal ... survey completed by sailors, researchers at Rhode Island Hospital have ... two types of boats -- dinghies (small boats with crews ...
... TUESDAY, Jan. 4 (HealthDay News) -- Rates of head and ... young women without any known risk factors. Now, a study ... the movement of precancerous cells in the mouth. ... estrogen after the lungs are exposed to smoke. This may ...
... 2011 - Normally, cortical nerve cells or neurons reside in ... in the white matter, but some people with schizophrenia have ... migration errors may arise in schizophrenia as a consequence of ... aberrant cellular localization has now been studied in detail in ...
... the leading cause of death in the developed world. ... have been defined, scientists continue to study other possible ... studies link infectious agents with the development of inflammatory ... pathogen Porphyromonas gingivalis is the induction of ...
Cached Medicine News:Health News:Fast Walkers May Have More Years Ahead of Them 2Health News:Fast Walkers May Have More Years Ahead of Them 3Health News:Watch out for that boom 2Health News:Watch out for that boom 3Health News:Estrogen May Play Role in Rising Rates of Head, Neck Cancer 2Health News:Neuronal migration errors: Right cells, wrong place 2Health News:Porphyromonas gingivalis accelerates inflammatory atherosclerosis in a mouse model 2
... The unparalleled Humphrey Lens Analyzers ... SPEXAN provide the most comprehensive lensometry ... the Humphrey Lens Analyzer (LA) gives ... for any lens-progressive lenses, prism lenses, ...
Lens Loading and Folding for Multipiece & Single-Piece ACRYSOF Lens with Standard Forceps...
... The Laserex Ultra Q is a hospital ... provides ophthalmologists with a precise, reliable means ... membranectomy. The system can be used ... opacification of the capsule (posterior capsulotomy), and ...
... The Laserex Super Q is an ... a precise and reliable means for performing ... The Super Q delivers benchmark performance in ... ,The Laserex Super Q produces a ...
Medicine Products: